Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTheranostics

Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy

Robert Seifert, Katharina Kessel, Martin Boegemann, Michael Köhler, Wolfgang Roll, Lars Stegger, Matthias Weckesser and Kambiz Rahbar
Journal of Nuclear Medicine May 2020, 61 (5) 723-728; DOI: https://doi.org/10.2967/jnumed.119.233429
Robert Seifert
1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katharina Kessel
1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Boegemann
2Department of Urology, University Hospital Münster, Münster, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Köhler
3Department of Clinical Radiology, University Hospital Münster, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Roll
1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Stegger
1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Weckesser
1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kambiz Rahbar
1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 61 no. 5 723-728
DOI 
https://doi.org/10.2967/jnumed.119.233429
PubMed 
31601703

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication July 8, 2019
  • Accepted for publication September 20, 2019
  • Published online May 1, 2020.

Article Versions

  • previous version (October 10, 2019 - 14:15).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Robert Seifert1,
  2. Katharina Kessel1,
  3. Martin Boegemann2,
  4. Michael Köhler3,
  5. Wolfgang Roll1,
  6. Lars Stegger1,
  7. Matthias Weckesser1 and
  8. Kambiz Rahbar1
  1. 1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
  2. 2Department of Urology, University Hospital Münster, Münster, Germany; and
  3. 3Department of Clinical Radiology, University Hospital Münster, Münster, Germany
  1. For correspondence or reprints contact: Kambiz Rahbar, Department of Nuclear Medicine, University Hospital Muenster, Albert Schweitzer Campus 1, Gebäude A1, 48149 Muenster, Germany. E-mail: rahbar{at}uni-muenster.de
View Full Text

Statistics from Altmetric.com

Cited By...

  • 15 Citations
  • 16 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)
    Robert Seifert, Louise Emmett, Steven P. Rowe, Ken Herrmann, Boris Hadaschik, Jeremie Calais, Frederik L. Giesel, Robert Reiter, Tobias Maurer, Matthias Heck, Andrei Gafita, Michael J. Morris, Stefano Fanti, Wolfgang A. Weber, Thomas A. Hope, Michael S. Hofman, Wolfgang Peter Fendler, Matthias Eiber
    European Urology 2023 83 5
  • Visceral Metastases as Predictors of Response and Survival Outcomes in Patients of Castration-Resistant Prostate Cancer Treated With 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy
    Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood
    Clinical Nuclear Medicine 2020 45 12
  • Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis
    Finn Edler von Eyben, Glenn Bauman, Rie von Eyben, Kambiz Rahbar, Cigdem Soydal, Alexander R. Haug, Irene Virgolini, Harshad Kulkarni, Richard Baum, Giovanni Paganelli
    International Journal of Molecular Sciences 2020 21 23
  • Value of Combined PET Imaging with [18F]FDG and [68Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [177Lu]Lu-PSMA-617 RLT
    Fadi Khreish, Kalle Ribbat, Mark Bartholomä, Stephan Maus, Tobias Stemler, Ina Hierlmeier, Johannes Linxweiler, Mathias Schreckenberger, Samer Ezziddin, Florian Rosar
    Cancers 2021 13 16
  • Is18F-FDG PET Needed to Assess177Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis
    Robert Seifert, Tugce Telli, Boris Hadaschik, Wolfgang P. Fendler, Phillip H. Kuo, Ken Herrmann
    Journal of Nuclear Medicine 2023 64 5
  • Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging
    Katharina Kessel, Robert Seifert, Matthias Weckesser, Martin Boegemann, Sebastian Huss, Clemens Kratochwil, Uwe Haberkorn, Frederik Giesel, Kambiz Rahbar
    Annals of Nuclear Medicine 2022 36 3
  • Computer-Aided Design of Lasso-like Self-Assembling Anticancer Peptides with Multiple Functions for Targeted Self-Delivery and Cancer Treatments
    Pengfei Pei, Long Chen, Ruru Fan, Xi-Rui Zhou, Shan Feng, Hangrui Liu, Quanqiang Guo, Huiwei Yin, Qiang Zhang, Fude Sun, Liang Peng, Peng Wei, Chengzhi He, Renzhong Qiao, Zai Wang, Shi-Zhong Luo
    ACS Nano 2022 16 9
  • The Potential of PSMA as a Vascular Target in TNBC
    Amelie Heesch, Lars Ortmanns, Jochen Maurer, Elmar Stickeler, Sabri E. M. Sahnoun, Felix M. Mottaghy, Agnieszka Morgenroth
    Cells 2023 12 4
  • Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management
    Katharina Kessel, Christof Bernemann, Martin Bögemann, Kambiz Rahbar
    Cancers 2021 13 14
  • Prostate Cancer Theranostics With 177Lu-PSMA
    Hojjat Ahmadzadehfar, Robert Seifert, Ali Afshar-Oromieh, Clemens Kratochwil, Kambiz Rahbar
    Seminars in Nuclear Medicine 2024 54 4

Article usage

Article usage: October 2019 to April 2025

AbstractFullPdf
Oct 2019490035
Nov 2019160010
Dec 20197904
Jan 202086010
Feb 20206402
Mar 20207006
Apr 202068012
May 2020773850
Jun 2020182814
Jul 202093214
Aug 20207812
Sep 20208807
Oct 202069116
Nov 202075513
Dec 2020282016
Jan 2021283021
Feb 2021264527
Mar 2021253926
Apr 2021354229
May 202193811
Jun 2021144410
Jul 2021172725
Aug 2021112713
Sep 2021192614
Oct 2021274943
Nov 2021254234
Dec 2021194530
Jan 2022114214
Feb 2022164218
Mar 2022235019
Apr 2022134024
May 202293618
Jun 2022123614
Jul 2022123812
Aug 2022174618
Sep 2022164716
Oct 2022225827
Nov 2022153718
Dec 202284510
Jan 202384915
Feb 2023114810
Mar 20239459
Apr 202394219
May 20235368
Jun 202377615
Jul 202314678
Aug 202374818
Sep 202386127
Oct 2023410114
Nov 202364614
Dec 20235999
Jan 202468513
Feb 20241476887
Mar 202475153
Apr 20241111730
May 2024147813
Jun 202424317
Jul 202484814
Aug 2024114216
Sep 202434426
Oct 2024105925
Nov 202464024
Dec 2024124620
Jan 2025147028
Feb 2025208719
Mar 202576925
Apr 2025125224
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (5)
Journal of Nuclear Medicine
Vol. 61, Issue 5
May 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy
Robert Seifert, Katharina Kessel, Martin Boegemann, Michael Köhler, Wolfgang Roll, Lars Stegger, Matthias Weckesser, Kambiz Rahbar
Journal of Nuclear Medicine May 2020, 61 (5) 723-728; DOI: 10.2967/jnumed.119.233429

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy
Robert Seifert, Katharina Kessel, Martin Boegemann, Michael Köhler, Wolfgang Roll, Lars Stegger, Matthias Weckesser, Kambiz Rahbar
Journal of Nuclear Medicine May 2020, 61 (5) 723-728; DOI: 10.2967/jnumed.119.233429
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Is 18F-FDG PET Needed to Assess 177Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis
  • Google Scholar

More in this TOC Section

Theranostics

  • Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
  • Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Show more Theranostics

Clinical

  • Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
  • Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Show more Clinical

Similar Articles

Keywords

  • PSMA
  • prostate cancer
  • SIRT
SNMMI

© 2025 SNMMI

Powered by HighWire